During a live event in the Oval Office, Novo Nordisk executive Gordon Findlay unexpectedly fainted next to President Donald Trump as he spoke about drug prices. The press was quickly removed from the room, and staff immediately provided assistance.
The White House confirmed that Findlay had fainted but assured he was "OK."
This incident has reignited discussions concerning the ongoing healthcare challenges in the United States and the rapid rise in medication costs.
The sudden fainting of a pharma executive at a White House event highlighted the intensity of debates surrounding America’s escalating drug prices.